| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |